SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-096507
Filing Date
2023-12-18
Accepted
2023-12-18 16:15:31
Documents
13
Period of Report
2023-12-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea190275-8k_inmune.htm   iXBRL 8-K 23526
2 PRESS RELEASE DATED DECEMBER 18, 2023 ea190275ex99-1_inmune.htm EX-99.1 12329
  Complete submission text file 0001213900-23-096507.txt   213921

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inmb-20231218.xsd EX-101.SCH 3018
4 XBRL LABEL FILE inmb-20231218_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inmb-20231218_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT ea190275-8k_inmune_htm.xml XML 3409
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 231493911
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)